Castle Biosciences CEO Derek J. Maetzold Reports Disposal of Common Shares
Castle Biosciences CEO Derek J. Maetzold reported the disposal of common shares of the company. The original filing is available via EDGAR, the SEC's system. This AI-generated news brief is for informational purposes and not financial advice.
Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences Inc., reported a disposal of common shares of Castle Biosciences Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-054126), on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
